GE HealthCare and Mayo Clinic aim to advance personalized cancer treatment through new theranostics research collaboration

Go back to GE HealthCare and Mayo Clinic aim to advance personalized cancer treatment through new theranostics research collaboration
(NASDAQ: GEHC) Delayed: 61.41 -0.63 (1.02%)
Previous Close $62.04    52 Week High
Open $62.39    52 Week Low
Day High $62.70    P/E N/A 
Day Low $61.34    EPS
Volume 3,057,769